For citations:
Pecherina T.B., Larionov M.V., Khan D.S., Shpagina L.A., Pudov E.V., Barbarash O.L. Experience of using idarucizumab, specific antagonist of dabigatran, in Russia. Medical alphabet. 2020;1(19):29-38. (In Russ.) https://doi.org/10.33667/2078-5631-2020-19-29-38
Views PDF (Rus): 175
Email this article 